| Neurocircuitry of addiction GF Koob, ND Volkow Neuropsychopharmacology 35 (1), 217-238, 2010 | 6103 | 2010 |
| Drug addiction, dysregulation of reward, and allostasis GF Koob, M Le Moal Neuropsychopharmacology 24 (2), 97-129, 2001 | 3710 | 2001 |
| Drug abuse: hedonic homeostatic dysregulation GF Koob, ML Moal Science 278 (5335), 52-58, 1997 | 3509 | 1997 |
| Neurobiology of addiction: a neurocircuitry analysis GF Koob, ND Volkow The Lancet Psychiatry 3 (8), 760-773, 2016 | 3029 | 2016 |
| Drugs of abuse: anatomy, pharmacology and function of reward pathways GF Koob Trends in pharmacological sciences 13, 177-184, 1992 | 2912 | 1992 |
| Cellular and molecular mechanisms of drug dependence GF Koob, FE Bloom Science 242 (4879), 715-723, 1988 | 2779 | 1988 |
| Neurobiologic advances from the brain disease model of addiction ND Volkow, GF Koob, AT McLellan New England Journal of Medicine 374 (4), 363-371, 2016 | 2006 | 2016 |
| Addiction and the brain antireward system GF Koob, M Le Moal Annu. Rev. Psychol. 59, 29-53, 2008 | 1695 | 2008 |
| Neuroscience of addiction GF Koob, PP Sanna, FE Bloom Neuron 21 (3), 467-476, 1998 | 1340 | 1998 |
| Transition from moderate to excessive drug intake: change in hedonic set point SH Ahmed, GF Koob Science 282 (5387), 298-300, 1998 | 1277 | 1998 |
| A role for brain stress systems in addiction GF Koob Neuron 59 (1), 11-34, 2008 | 1219 | 2008 |
| Plasticity of reward neurocircuitry and the'dark side'of drug addiction GF Koob, M Le Moal Nature neuroscience 8 (11), 1442-1444, 2005 | 1155 | 2005 |
| Stress, dysregulation of drug reward pathways, and the transition to drug dependence G Koob, MJ Kreek American journal of psychiatry 164 (8), 1149-1159, 2007 | 1035 | 2007 |
| Mice deficient for corticotropin-releasing hormone receptor-2 display anxiety-like behaviour and are hypersensitive to stress TL Bale, A Contarino, GW Smith, R Chan, LH Gold, PE Sawchenko, ... Nature genetics 24 (4), 410-414, 2000 | 1035 | 2000 |
| Neurobiological similarities in depression and drug dependence: a self-medication hypothesis A Markou, TR Kosten, GF Koob Neuropsychopharmacology 18 (3), 135-174, 1998 | 1033 | 1998 |
| Corticotropin releasing factor receptor 1–deficient mice display decreased anxiety, impaired stress response, and aberrant neuroendocrine development GW Smith, JM Aubry, F Dellu, A Contarino, LM Bilezikjian, LH Gold, ... Neuron 20 (6), 1093-1102, 1998 | 1011 | 1998 |
| Neurobiology of addiction GF Koob Focus 9 (1), 55-65, 2011 | 963 | 2011 |
| Corticotropin releasing factor produces behavioural activation in rats RE Sutton, GF Koob, M Le Moal, J Rivier, W Vale Nature 297 (5864), 331-333, 1982 | 961 | 1982 |
| Extinction and recovery of cocaine self-administration following 6-hydroxydopamine lesions of the nucleus accumbens DCS Roberts, GF Koob, P Klonoff, HC Fibiger Pharmacology Biochemistry and Behavior 12 (5), 781-787, 1980 | 958 | 1980 |
| Dopamine, schizophrenia, mania, and depression: toward a unified hypothesis of cortico-striatopallido-thalamic function NR Swerdlow, GF Koob Behavioral and brain sciences 10 (2), 197-208, 1987 | 921 | 1987 |
